Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Zosano Pharma (ZSAN)

Zosano Pharma (ZSAN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 114,793
  • Shares Outstanding, K 106,290
  • Annual Sales, $ 220 K
  • Annual Income, $ -33,370 K
  • 60-Month Beta 3.95
  • Price/Sales 507.72
  • Price/Cash Flow N/A
  • Price/Book 2.38
Trade ZSAN with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.07
  • Number of Estimates 1
  • High Estimate -0.07
  • Low Estimate -0.07
  • Prior Year -0.24
  • Growth Rate Est. (year over year) +70.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0200 unch
on 04/15/21
1.5200 -32.89%
on 03/17/21
-0.3800 (-27.14%)
since 03/15/21
3-Month
0.8500 +20.00%
on 01/27/21
3.0600 -66.67%
on 02/09/21
+0.1575 (+18.26%)
since 01/15/21
52-Week
0.3275 +211.45%
on 11/06/20
3.0600 -66.67%
on 02/09/21
+0.2694 (+35.89%)
since 04/15/20

Most Recent Stories

More News
Thinking about buying stock in FSD Pharma, Onconova Therapeutics, Nabriva Therapeutics, Zosano Pharma, or Savara?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for HUGE, ONTX, NBRV, ZSAN, and SVRA.

HUGE : 1.5900 (-10.17%)
NBRV : 1.5700 (+6.08%)
SVRA : 1.6800 (-2.89%)
ONTX : 0.6301 (-8.96%)
ZSAN : 1.0200 (-5.56%)
Zosano Pharma Reports Fourth Quarter and Fiscal Year 2020 Financial Results

Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the fourth quarter and year ended December 31, 2020, as well as business highlights....

ZSAN : 1.0200 (-5.56%)
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Zillow Group and Zosano Pharma and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating certain officers and directors of Zillow Group, Inc. (NASDAQ: Z) and Zosano Pharma Corporation (NASDAQ:...

ZG : 143.25 (+2.85%)
Z : 141.40 (+3.62%)
ZSAN : 1.0200 (-5.56%)
Zosano Pharma to Present at the H.C. Wainwright Global Life Sciences Conference

Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its president and chief executive officer, Steven Lo, will present a company overview at the H.C....

ZSAN : 1.0200 (-5.56%)
Zosano Pharma Confirms NDA Resubmission Strategy Following Type A Meeting Minutes from FDA

Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that the company has received the official Type A meeting minutes from the U.S. Food and Drug Administration...

ZSAN : 1.0200 (-5.56%)
Thinking about buying stock in Seelos Therapeutics, Celsion Corp, Zosano Pharma, Outlook Therapeutics, or Infinity Pharmaceuticals?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SEEL, CLSN, ZSAN, OTLK, and INFI.

INFI : 3.08 (-1.28%)
OTLK : 1.9000 (+1.60%)
SEEL : 5.28 (+9.54%)
CLSN : 1.1900 (-4.80%)
ZSAN : 1.0200 (-5.56%)
Thinking about buying stock in Heat Biologics, Zosano Pharma, Glu Mobile, AzurRx BioPharma, or Abeona Therapeutics?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for HTBX, ZSAN, GLUU, AZRX, and ABEO.

GLUU : 12.46 (unch)
ABEO : 1.5000 (-6.25%)
AZRX : 0.8100 (-4.71%)
HTBX : 6.58 (-2.95%)
ZSAN : 1.0200 (-5.56%)
Zosano Pharma Presents Early-Onset of Action Data for Qtrypta(TM) in Acute Treatment of Migraines

-- Review of data from the ZOTRIP trial suggest that Qtrypta showed therapeutic gain at 30 minutes consistent with recently published criteria for evaluating early onset of action

ZSAN : 1.0200 (-5.56%)
Zosano Pharma Announces NDA Resubmission Plans Following Type A Meeting with FDA

Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that the company completed its Type A meeting with the U.S. Food and Drug Administration ("FDA") Division...

ZSAN : 1.0200 (-5.56%)
4 Downgraded Stocks to AVOID

The market is starting to encounter some volatility after mostly smooth sailing since November. While, there's good reason to believe this dip is buyable, investors need to be wary that certain stocks...

GMBL : 12.00 (-5.06%)
USAP : 9.21 (+0.22%)
OBLN : 2.31 (-9.06%)
ZSAN : 1.0200 (-5.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Zosano Pharma Corporation is a biopharmaceutical company. It is engaged in developing a transdermal micro needle patch system to deliver formulations of existing drugs through the skin for the treatment of a variety of indications. The Company's lead product candidates include Weekly ZP-PTH for severe...

See More

Key Turning Points

3rd Resistance Point 1.1200
2nd Resistance Point 1.1000
1st Resistance Point 1.0600
Last Price 1.0200
1st Support Level 1.0000
2nd Support Level 0.9800
3rd Support Level 0.9400

See More

52-Week High 3.0600
Fibonacci 61.8% 2.0162
Fibonacci 50% 1.6937
Fibonacci 38.2% 1.3713
Last Price 1.0200
52-Week Low 0.3275

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar